Emergency Use Authorisation

DCGI Recommends Emergency Use Authorisation To SII's Covovax For Children Aged 7-11 Years

SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years

Biological E Applies For EUA For Covid-19 Vaccine Corbevax For 5-12 Age Group: Report

Aurobindo Pharma Launches Covid Drug Molnupiravir After ICMR Chief’s ‘Major Safety Concerns’ Advice

CDSCO Panel Recommends Emergency Use Authorisation For SII's Covid vaccine Covovax

G20 Leaders To Strengthen WHO In Optimising Covid Vaccine Approval Process: Piyush Goyal

Vaccination Of Children & Adolescents To Be Based On ‘Scientific Rationale’, ‘Supply Situation’: Covid Task Force Chief

Pfizer To Get Emergency Use Authorisation For Vaccines In Children Aged 5 to 12 By Oct: Former FDA Chief

Mukesh Ambani’s Reliance Life Sciences Seeks Nod For Covid Vaccine Trial: Report

Bharat Biotech’s Covaxin To Get WHO Emergency Use Authorisation Nod By September: Report

Health Ministry Denies Reports Of Rejection Of SII, Bharat Biotech Emergency Use Authorisation

Corona Vaccine Emergency Approval: What Does Emergency Use Authorisation Means For Pharma Companies?